Hospital POVISA-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study

    Medicine (United States), Vol. 101, Núm. 24, pp. E29252